Founded in 2009 and launched in early 2011, Medikly offers an enterprise-grade, multi-channel marketing platform for pharmaceutical marketers that combines content, Big Data analytics and social. Its core technology includes a "Preference Discovery Engine" that identifies physician behavior and relationships, a personalization layer that tailors outreach, and an analytics engine to optimize campaigns in real time. The product is aimed at reducing campaign spend while improving targeting and measurable ROI for Big Pharma. Medikly graduated from the Blueprint Health accelerator and spent much of 2012 building and pivoting its platform. The company had no sales through November 2012 but, after opening the platform post-demo day, closed $960K in bookings in December and reported $900K in February. Based on that pace, the founder said Medikly was on track to hit $5.6M in sales for the quarter. Medikly offers KONNECT, a scalable cloud-based framework that delivers deeper content, in-depth interactive experiences, and a robust set of engagement analytics for healthcare stakeholders. KONNECT captures and measures involvement, interaction, influence and sentiment over time across online and offline data sources. Medikly positions its product as providing a data and technology infrastructure to better understand audience behaviors and continuously measure and act on engagement—beyond impressions, visits and duration. The company says KONNECT enables stakeholders to identify influential customers and providers and to track changes in providers’ intent to prescribe. Medikly intends to grow and scale KONNECT through a new strategic partnership and investment with Strategic America, targeting expansion into healthcare and pharma. The company is described as a social media startup and did not disclose financial metrics in the announcement.

Total raised

$1M

Funding rounds

2

Latest round

Series A

Latest activity

Feb 2013